DEF: Option Care Health Schedules 2026 Annual Meeting

Option Care Health, Inc. has released its 2026 Proxy Statement, detailing proposals for director elections, auditor ratification, and executive compensation, alongside a review of its 2025 performance and corporate governance.

Summary

• Option Care Health is holding its 2026 Annual Meeting of Stockholders on May 20, 2026, to elect nine directors, ratify KPMG LLP as its independent auditor for 2026, and approve executive compensation on an advisory basis.
• The company reported strong 2025 financial highlights, including $5.65 billion in net revenue (13% growth), $471.3 million in Adjusted EBITDA (6.2% growth), and $1.72 in Adjusted EPS (8.9% growth).
• Key governance enhancements approved in 2025 include granting stockholders the right to request special meetings.
• The company welcomed Meenal Sethna as the new Chief Financial Officer in August 2025, succeeding Mike Shapiro.
• Two long-serving directors, Elizabeth Q. Betten and David W. Golding, will not be on the Board after the Annual Meeting.
• The Board of Directors comprises nine nominees, with five having joined since 2022, reflecting a focus on refreshment and diverse skills.
• Executive compensation is heavily weighted towards performance-based incentives, with approximately 88% of target CEO compensation tied to corporate performance.
• The company's Audit and Finance Committee re-appointed KPMG LLP as its independent registered public accounting firm for 2026, a role KPMG has held since 2015.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, highlighting strong revenue and operational performance, good corporate governance enhancements, and positive stockholder engagement, while acknowledging a slight dip in net income.

Positives

• Achieved 13% net revenue growth in 2025, reaching $5.65 billion.
• Generated $258 million in operating cash flow in 2025.
• Increased Adjusted EBITDA by 6.2% to $471.3 million in 2025.
• Increased Adjusted EPS by 8.9% to $1.72 in 2025.
• Stockholders overwhelmingly approved governance enhancements in 2025, including the right to request special meetings.
• Strong stockholder support for executive compensation, with approximately 98% of votes cast in favor of the say-on-pay proposal in 2025.
• Board composition is being refreshed, with five of the nine nominees joining since 2022.
• Robust stock ownership guidelines are in place for directors and executive officers.
• The company was named a Leading Disability Employer and a Military Friendly Employer in 2025.

Negatives

• Net income decreased by 2.0% in 2025 to $207.6 million.
• GAAP diluted earnings per share saw a modest increase of 3.3% to $1.27 in 2025.
• One Form 4 filing for several directors was one business day late due to administrative error.

Risks

• The filing mentions that forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the company's control.
• The company's periodic reports filed with the SEC identify risk factors that could affect actual results.

Future Outlook

The company expresses optimism for the future, driven by its mission, talented team, and strong operational and financial performance. Investments are being made to strengthen the foundation and deliver returns to stockholders through targeted acquisitions, share repurchases, and capability enhancements. Management is committed to capital allocation with discipline and vision to create enduring stockholder value.

Management Comments

• "At Option Care Health, our mission - to provide extraordinary care that changes lives - is more than a statement. It is the promise that inspires us and guides every interaction with the patients and families who depend on us."
• "The impact of our teams was reflected not only in the care they provided but also in our strong operational and financial performance."
• "Whether through targeted acquisitions, share repurchases, or ongoing investments in our capabilities, the Board and I remain committed to allocating capital with discipline and vision - always with the goal of creating enduring value for our stockholders."
• "We believe that meaningful engagement with our stockholders is essential to strong governance."
• "As expectations evolve, so will we - and we will continue to listen."
• "Meenal brings outstanding experience at a number of large organizations and a deep commitment to operational excellence. She has already made a meaningful impact, and I am confident she will help guide the next chapter of our growth."
• "As we look ahead, I am energized by the opportunities in front of us. We are operating from a position of strength - with a talented team and an unwavering mission."

Industry Context

StockSavvy.ai notes that Option Care Health's focus on high-growth areas within healthcare services, particularly infusion therapy, aligns with broader industry trends of increasing demand for specialized, home-based, and value-based care solutions. The company's financial performance, including revenue growth and Adjusted EBITDA, reflects its ability to scale operations and manage costs in a competitive landscape.

Comparison to Industry Standards

• The company's peer group for compensation benchmarking includes companies like Acadia Healthcare Company, Inc., Addus HomeCare Corporation, AdaptHealth Corp., agilon health, inc., Amedisys, Inc., AMN Healthcare Services, Inc., BrightSpring Health Services, Inc., Chemed Corporation, DaVita Inc., Enhabit Inc., Encompass Health Corporation, The Ensign Group, Inc., Labcorp Holdings Inc., Owens & Minor, Inc., Patterson Companies, Inc., Quest Diagnostics Incorporated, and Select Medical Holdings Corporation. These companies are selected based on market capitalization and revenue similarity, sector representation, and key competitor status.
• The 2025 Adjusted EBITDA target represented an approximately 5% increase over actual 2024 results, and the 2025 revenue target represented an approximately 7% increase over actual 2024 results, reflecting growth expectations aligned with peer companies.
• The company's use of non-GAAP financial measures like Adjusted EBITDA and Adjusted EPS is common practice within the healthcare services industry to provide a clearer view of operational performance.
• The compensation committee's decision to increase Mr. Grashoff's base salary was to align it more closely with market benchmarks for similar roles, indicating a focus on competitive compensation within the industry.

Management Changes

Corporate Governance

Related Party Transactions

• The company has a written policy for the approval of transactions exceeding $120,000 between the company and its directors, executive officers, director nominees, greater than 5% beneficial owners, and their immediate family members, where the related party has a material interest. These transactions are reviewed and approved by the Audit and Finance Committee.

Stakeholder Impact

• Shareholders: The company's financial performance, capital allocation strategies (acquisitions, share repurchases), and governance enhancements are intended to create enduring value for stockholders. The strong say-on-pay vote indicates alignment with executive compensation practices.
• Employees: The company highlights its mission to provide extraordinary care and its commitment to its 8,000 professionals, including over 5,000 clinicians. Recognition as a Leading Disability Employer and Military Friendly Employer suggests a positive workplace environment.
• Patients: The core mission is focused on providing extraordinary care to patients navigating complex health journeys.
• Creditors: The company's financial health, including its net debt leverage ratio of 2.0x, is relevant to creditors.

Next Steps

• Election of nine directors at the 2026 Annual Meeting of Stockholders.
• Ratification of KPMG LLP as the independent registered public accounting firm for 2026.
• Advisory vote to approve named executive officer compensation.
• Continued engagement with stockholders on corporate governance, executive compensation, and sustainability practices.
• Ongoing investments in capabilities through targeted acquisitions and other strategic initiatives.

Key Dates

Recommendation

The filing presents a mixed picture. While revenue and Adjusted EBITDA show solid growth, net income has slightly declined. The company is making strategic investments and has strong governance practices, but the slight decrease in net income and the upcoming annual meeting with director elections and compensation votes warrant a cautious 'hold' stance until further clarity on future performance and strategic execution emerges.

Keywords

Option Care Health, Proxy Statement, Annual Meeting, Director Election, Executive Compensation, Corporate Governance, KPMG LLP, Auditor Ratification, Financial Performance, Stockholder Engagement